Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood
Open Access
- 26 November 2002
- Vol. 49 (4), 150-158
- https://doi.org/10.1002/cyto.10161
Abstract
Background: The detection of disseminated tumor cells in peripheral blood is limited by the presence of very few tumor cells within a large number of blood cells. Therefore, tumor cell detection calls for enrichment systems with effective depletion of blood cells and high tumor cell recovery.Methods: We compared the new density gradient centrifugation method OncoQuick with the standard method of Ficoll. The enriched cell fractions were quantified. Tumor cell spiking experiments examined the recovery of tumor cells as detected by immunocytochemistry and cytokeratin‐20 reverse transcriptase–polymerase chain reaction (RT‐PCR). Clinical application of OncoQuick was evaluated in 37 peripheral blood samples of patients with gastrointestinal carcinomas.Results: The depletion of mononuclear cells (MNCs) in the enriched cell fraction after OncoQuick centrifugation was 632‐fold, with an average cell number of 9.5 × 104, compared with Ficoll, with a depletion factor of 3.8 and a mean number of 1.6 × 107 MNCs. The mean tumor cell recovery rates were 87% for OncoQuick and 84% for Ficoll. The increased depletion of MNCs with OncoQuick centrifugation further simplified immunocytochemical evaluation by reducing the number of cytospins and increasing the tumor cell density. Due to the reduced number of co‐enriched MNCs by OncoQuick, the blood volume, which could be analyzed in one RT‐PCR reaction, was increased up to 30 ml. Examination of peripheral blood samples from 37 patients with gastrointestinal tumors showed a cytokeratin‐20 detection rate of 30% and a significant correlation with the presence of distant metastases (P < 0.02).Conclusions: OncoQuick significantly reduced the co‐enriched number of MNCs, with a high tumor cell recovery rate. Processing blood from tumor patients with OncoQuick increased the chance of detecting circulating tumor cells. Cytometry 49:150–158, 2002.This publication has 23 references indexed in Scilit:
- Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancerSeminars in Surgical Oncology, 2001
- Technical aspects of minimal residual disease detection in carcinoma patientsSeminars in Surgical Oncology, 2001
- Surgical strategies and minimal residual disease detectionSeminars in Surgical Oncology, 2001
- Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancerGastroenterology, 2001
- Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosisInternational Journal of Colorectal Disease, 2001
- Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancerBritish Journal of Cancer, 2000
- Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumoursEuropean Journal Of Cancer, 2000
- Detection and clinical relevance of micrometastatic cancer cellsCurrent Opinion in Oncology, 2000
- Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cellsCytotherapy, 1999
- Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.Journal of Clinical Oncology, 1998